![Erik Ostrowski](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Erik Ostrowski
Directeur Financier/CFO chez
AKEBIA THERAPEUTICS, INC.
Fortune : 686 088 $ au 31/05/2026
Profil
Erik John Ostrowski currently serves as Treasurer, Chief Financial & Business Officer at Akebia Therapeutics, Inc. since 2024 and as Chief Financial Officer at Keryx Biopharmaceuticals, Inc. Former roles include President, Chief Executive Officer & Treasurer at AVROBIO, Inc. from 2019 to 2024; Director at Leerink Partners LLC; Non-Executive Director at Faron Pharmaceuticals Oy from 2022 to 2024; Vice President-Finance at Organogenesis, Inc. from 2010 to 2014; Accountant at PricewaterhouseCoopers LLP; Chief Financial Officer at Summit Therapeutics Ltd. from 2014 to 2018; and President at Tectonic Therapeutic, Inc. and Tectonic Operating Co., Inc. Education includes an undergraduate degree from Babson College and an MBA from The University of Chicago Booth School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 672 635 ( 0,25% ) | 686 088 $ | 31/05/2026 |
Postes actifs de Erik Ostrowski
| Sociétés | Poste | Début |
|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Directeur Financier/CFO | 24/06/2024 |
| KERYX BIOPHARMACEUTICALS | Directeur Financier/CFO | - |
Anciens postes connus de Erik Ostrowski
| Sociétés | Poste | Fin |
|---|---|---|
| TECTONIC THERAPEUTIC, INC. | Directeur Général | 20/06/2024 |
| FARON PHARMACEUTICALS OY | Directeur/Membre du Conseil | 05/04/2024 |
Summit Therapeutics Ltd.
 Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of novel medicines | Directeur Financier/CFO | 28/12/2018 |
Organogenesis, Inc.
 Organogenesis, Inc. Medical SpecialtiesHealth Technology Designs and manufactures regenerative medical products | Directeur Financier/CFO | 01/06/2014 |
Formation de Erik Ostrowski
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
23
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Organogenesis, Inc.
Organogenesis, Inc. Medical SpecialtiesHealth Technology Designs and manufactures regenerative medical products | Health Technology |
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Commercial Services |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of novel medicines | Health Technology |
Leerink Partners LLC
 Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Babson College
 Babson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Faron Pharmaceuticals Oy
 Faron Pharmaceuticals Oy Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Akebia Therapeutics, Inc.
 Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
The University of Chicago Booth School of Business
 The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AVROBIO, Inc.
 AVROBIO, Inc. BiotechnologyHealth Technology Develops potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases in a single dose | Health Technology |
Tectonic Therapeutic, Inc.
 Tectonic Therapeutic, Inc. Miscellaneous Commercial ServicesCommercial Services Operates biotechnology company that transforming the discovery of novel G-protein-coupled receptors targeted therapies | Commercial Services |
